Arrowhead Pharmaceuticals Inc. Latest Ownership Pattern - Insider, Institutional, Mutual Fund shareholdings

Arrowhead Pharmaceuticals Inc. XNAS: ARWR

Momentum Trap

28.00 0.20 (0.72%)

3.3M

XNAS Volume

XNAS 04 Sep, 2025 4:19 PM (EDT)

Drug Deal

Arrowhead grants Novartis exclusive rights to neuromuscular therapy in deal worth up to $2 bn See details